Caribou Biosciences (CRBU) Equity Ratio (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of Equity Ratio data on file, last reported at 0.68 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.68, down 13.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.68 (down 13.74% YoY), and the FY2025 annual result was 0.7, down 13.71% from the prior year.
• Equity Ratio eased to 0.68 in Q1 2026 per CRBU's latest filing, from 0.7 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.87 in Q3 2023 and troughed at 0.68 in Q1 2026.
• A 5-year average of 0.8 and a median of 0.81 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2022 and 2026: Equity Ratio soared 374.21% in 2022, then dropped 13.74% in 2026.
• A 5-year view of Equity Ratio shows it stood at 0.8 in 2022, then grew by 5.89% to 0.85 in 2023, then slipped by 5.28% to 0.81 in 2024, then decreased by 13.71% to 0.7 in 2025, then declined by 1.72% to 0.68 in 2026.
• Business Quant data shows CRBU's Equity Ratio at 0.68 in Q1 2026, 0.7 in Q4 2025, and 0.73 in Q3 2025.